Fig. 4From: SGLT-2 inhibitors and cardiorenal outcomes in patients with or without type 2 diabetes: a meta-analysis of 11 CVOTsForest plots examining the composite outcome of cardiovascular death or hospitalization for heart failure in participants of three CVOTs with age > 65 years (top) or ≤ 65 years (bottom). There is no heterogeneity in the analyses (I2 = 0–2%) and difference between the two groups (P interaction = 0.78)Back to article page